News
Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...
Here are Investing.com’s stocks of the week. Microsoft was one of many tech giants that reported earnings this week, with the company topping profit and revenue expectations. MSFT shares jumped more ...
In 2023, experts decided against adding obesity drugs to the World Health Organisation's essential medicines list.
That is why the current wave of fake Ozempic-style drugs now circulating in the U.S by unlicensed and often foreign companies ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Viking is developing what might be a game-changing medication in the segment. Viking Therapeutics (NASDAQ: VKTX), a biotech ...
Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo ...
Misperceptions and a focus on weight-loss medications risk oversimplifying a complex health crisis. Read more at straitstimes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results